TP-008

TP-008 : Inhibitor of ACVR1B, TGFBR1

Structure

Information

  • ACVR1B
  • TGFBR1
  • Inhibitor
  • 1-10 uM

In Vitro Validations

Uniprot ID: P36896
Target Class: Kinase
Target SubClass: TKL
Potency: IC50
Potency Value: 25 nM
Potency Assay: Lanthascreen
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Activin receptor type-1B, ALK4, ACVRLK4, ACVR1B, A ...

DOI Reference: 10.1021/acschembio.0c00076

Uniprot ID: P36896
Target Class: Kinase
Target SubClass: TKL
Potency: IC50
Potency Value: 300 nM
Potency Assay: Radioactive kinase assay (Reaction Biology)
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Activin receptor type-1B, ALK4, ACVRLK4, ACVR1B, A ...

DOI Reference: 10.1021/acschembio.0c00076

In Cell Validations

In Vivo Data

No in Vivo Validations

Off-Target Selectivity Assesments

Probe Selectivity in Vitro:
Clean KINOMEscan; off targets > 20 µM in NanoBRET. Selectivity outside target family: Closest off-targets: HTR2B 65% inhibition, PDE10A 73% inhibition (Diversity panel (Ricerca) results at 10 µM). Clean GPCR scan except for activity on HTR2B (70 % inhibition, Ki = 1881 nM)
I have extra information to add

SERP ratings and comments


SERP+ Ratings

In Cell Rating

SERP+ Comments:

The compound is very well characterised but potency varies significantly, between the different assays. The IC50 values determined in the radioactive kinase assay are high for a chemical probe (345 nM ALK5). The cellular data for the NanoBRET is slightly to high (5,7 uM for ALK5) but lower in a reporter assay with IC50s of about (245 nM for ALK5 and 526 nM for ALK4). potentially, high concentrations (double-digit µM range) will have to be used to reach IC95. The selectivity assay has shown no off targets at 1 uM but this concentration was not high enough to show 30 fold selectivity. The compound has good working control compounds but shows heart toxicity.

(last updated: 17 Jun 2024 )